学校法人順天堂　研究者情報データベース:::研究業績詳細:::

HOME　＞　研究業績詳細

研究業績詳細

猪俣武範（イノマタタケノリ）

研究テーマ	眼科一般、角膜、角膜移植、免疫、炎症、ドライアイ、虹彩、疫学、網膜、経営、リーダーシップ、IoT、IoMT、AI
研究業績（論文）	「英文原著【総数52編・筆頭著者数22編・責任著者(corresponding author)数32編】」 1. Inomata T, Ebihara N, Funaki T, Matsuda A, Watanabe Y, Ning L, Xu Z, Murakami A, Arikawa-Hirasawa E: Perlecan-deficient mutation impairs corneal epithelial structure. Invest Ophthalmol Vis Sci. 53(3):1277-84, 2012, IF:4.799 / CI:38. 2. Hua J, Jin Y, Chen Y, Inomata T, Lee H, Chauhan SK, Petasis NA, Serhan CN, Dana R: The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation. Invest Ophthalmol Vis Sci. 55(9):5944-51, 2014, IF:4.799 / CI:49. 3. Inomata T, Mashaghi A, Di Zazzo A, Dana R: Ocular surgical models for immune and angiogenic responses. J Biol Methods. 2(3), 2015, IF:– /CI:26. 4. Xu J, Hong J, Sun X, Liu Z, Mashaghi A, Inomata T, Lu Y, Li Y, Wu D, Yang Y, Wei A, Zhao Y, Lu C: Combined Lacrimal Passage Probing and Tobramycin/Dexamethasone Ophthalmic Ointment Infiltration: A Minimally Invasive Surgical Procedure for Incomplete Nasolacrimal Duct Obstruction. Medicine (Baltimore). 94(36):e1483, 2015, IF:1.889 / CI:7. 5. Hua J, Stevenson W, Dohlman TH, Inomata T, Tahvildari M, Calcagno N, Pirmadjid N, Sadrai Z, Chauhan SK, Dana R: Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis. Invest Ophthalmol Vis Sci. 57(3):1457-67, 2016, IF:4.799 /CI:25. 6. Inomata T (Corresponding Author), Honda M, Murakami A: Atypical VZV Retinitis in a Patient with Good Syndrome. Ocul Immunol Inflamm.1-5, 2016, IF:3.070 /CI:6. 7. Inomata T, Hua J, Di Zazzo A, Dana R: Impaired Function of Peripherally Induced Regulatory T Cells in Hosts at High Risk of Graft Rejection. Sci Rep. 6:39924, 2016, IF:4.380 / CI:36. 8. Tahvildari M, Omoto M, Chen Y, Emami-Naeini P, Inomata T, Dohlman TH, Kaye AE, Chauhan SK, Dana R: In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation. Transplantation. 100(3):525-32, 2016, IF:4.939 / CI:71. 9. Chen Y, Chauhan SK, Shao C, Omoto M, Inomata T, Dana R: IFN-gamma-Expressing Th17 Cells Are Required for Development of Severe Ocular Surface Autoimmunity. Journal of immunology. 199(3):1163-9, 2017, IF:5.422 / CI:59. 10. Di Zazzo A, Tahvildari M, Subbarayal B, Yin J, Dohlman TH, Inomata T, Mashaghi A, Chauhan SK, Dana R: Proangiogenic Function of T Cells in Corneal Transplantation. Transplantation. 101(4):778-85, 2017, IF:4.939 / CI:22. 11. Inomata T, Mashaghi A, Di Zazzo A, Lee SM, Chiang H, Dana R: Kinetics of Angiogenic Responses in Corneal Transplantation. Cornea. 36(4):491-6, 2017, IF:2.651 / CI:29. 12. Inomata T, Mashaghi A, Hong J, Nakao T, Dana R: Scaling and maintenance of corneal thickness during aging. PloS one. 12(10):e0185694, 2017, IF:3.240 / CI:13. 13. Inomata T (Corresponding Author), Ono K, Matsuba T, Shiang T, Di Zazzo A, Nakatani S, Yamaguchi M, Ebihara N, Murakami A: Pre-banking microbial contamination of donor conjunctiva and storage medium for penetrating keratoplasty. Jpn J Ophthalmol. 61(5):369-77, 2017, IF:2.447 / CI:5. 14. Qi H, Chen Y, Inomata T, Amouzegar A, Dana R: IL-10-Producing Th17 Cells: A Potentially Regulatory Cell Population in Dry Eye Disease. Journal of Immunology and Immunotherapy. 2(1:5), 2017, IF:0.33 / CI3. 15. Hua J, Inomata T, Chen Y, Foulsham W, Stevenson W, Shiang T, Bluestone JA, Dana R: Pathological conversion of regulatory T cells is associated with loss of allotolerance. Sci Rep. 8(1):7059, 2018, IF:4.380 / CI:65. 16. Inomata T, Hua J, Nakao T, Shiang T, Chiang H, Amouzegar A, Dana R: Corneal Tissue From Dry Eye Donors Leads to Enhanced Graft Rejection. Cornea. 37(1):95-101, 2018, IF:2.651 / CI:20. 17. Inomata T (Corresponding Author), Iwagami M, Hiratsuka Y, Fujimoto K, Okumura Y, Shiang T, Murakami A: Maximum blink interval is associated with tear film breakup time: A new simple, screening test for dry eye disease. Sci Rep. 8(1):13443, 2018, IF:4.380 / CI:7. 18. Inomata T (Corresponding Author), Mizuno J, Iwagami M, Kawasaki S, Shimada A, Inada E, Shiang T, Amano A: The impact of Joint Commission International accreditation on time periods in the operating room: A retrospective observational study. PloS one. 13(9):e0204301, 2018, IF:3.240 / CI:18. 19. Inomata T (Corresponding Author), Shiang T, Iwagami M, Sakemi F, Fujimoto K, Okumura Y, Ohno M, Murakami A: Changes in Distribution of Dry Eye Disease by the New 2016 Diagnostic Criteria from the Asia Dry Eye Society. Sci Rep. 8(1):1918, 2018, IF:4.380 / CI:27. 20. Ogawa M, Inomata T (Corresponding Author), Shiang T, Tsubota K, Murakami A: Method for selective quantification of immune and inflammatory cells in the cornea using flow cytometry. J Biol Methods. 5(4):e102, 2018, IF: – /CI:9. 21. Takei M, Obana A, Inomata T (Corresponding Author), Tanaka T, Shiang T, Bae Y, Takemura T, Murakami A: Fundus changes in type III membranoproliferative glomerulonephritis: a case report. BMC Ophthalmol. 18(1):72, 2018, IF:2.209 / CI:5. 22. Tan X, Chen Y, Foulsham W, Amouzegar A, Inomata T, Liu Y, Chauhan SK, Dana R: The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease. Ocul Surf. 2018, IF:5.033 /CI:21. 23. Inomata T (Corresponding Author), Nakamura M, Iwagami M, Shiang T, Yoshimura Y, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Hori S, Hiratsuka Y, Uchino M, Tsubota K, Dana R, Murakami A: Risk Factors for Severe Dry Eye Disease: Crowdsourced Research Using DryEyeRhythm. Ophthalmology. 126(5):766-8, 2019, IF:12.079 /CI:22. 24. Midorikawa-Inomata A, Inomata T (Corresponding Author), Nojiri S, Nakamura M, Iwagami M, Fujimoto K, Okumura Y, Iwata N, Eguchi A, Hasegawa H, Kinouchi H, Murakami A, Kobayashi H: Reliability and validity of the Japanese version of the Ocular Surface Disease Index for dry eye disease. BMJ Open. 9(11):e033940, 2019, IF:2.692 /CI:24. 25. Muto T, Nishimura T, Sakamoto M, Inomata T, Machida S: Identification of eyes at risk of acute primary angle-closure in elderly Japanese patients. Clin Ophthalmol. 13:859-68, 2019, IF:0.77 /CI:3. 26. Okumura Y, Inomata T (Corresponding Author), Iwagami M, Eguchi A, Mizuno J, Shiang T, Kawasaki S, Shimada A, Inada E, Amano A, Murakami A: Shortened cataract surgery by standardisation of the perioperative protocol according to the Joint Commission International accreditation: a retrospective observational study. BMJ Open. 9(6):e028656, 2019, IF:2.692 /CI:5. 27. Okumura Y, Inomata T (Corresponding Author), Miyamoto S, Nakatani S, Hiratsuka Y, Yamaguchi M, Iwamoto S, Murakami A: Donor Characteristics and Risk Factors for Methicillin-Resistant Staphylococcus aureus Contamination in Storage Medium for Corneal Transplantation: A 10-year Retrospective Study. Transpl Infect Dis.e13123, 2019, IF:2.228 /CI:3. 28. Fujimoto K, Inomata T (Corresponding Author), Okumura Y, Iwata N, Fujio K, Eguchi A, Nagino K, Shokirova H, Karasawa M, Murakami A: Comparison of corneal thickness in patients with dry eye disease using the Pentacam rotating Scheimpflug camera and anterior segment optical coherence tomography. PloS one. 15(2), 2020, IF:3.240 / CI:5. 29. Hirosawa K, Inomata T (Corresponding Author), Sung J, Nakamura M, Okumura Y, Midorikawa-Inomata A, Miura M, Fujio K, Akasaki Y, Fujimoto K, Zhu J, Eguchi A, Nagino K, Kuwahara M, Shokirova H, Yanagawa A, Murakami A: Diagnostic ability of maximum blink interval together with Japanese version of Ocular Surface Disease Index score for dry eye disease. Sci Rep. 10(1):18106, 2020, IF:4.380 / CI:7. 30. Inomata T (Corresponding Author), Fujimoto K, Okumura Y, Zhu J, Fujio K, Shokirova H, Miura M, Okano M, Funaki T, Sung J, Negishi N, Murakami A: Novel immunotherapeutic effects of topically administered ripasudil (K-115) on corneal allograft survival. Sci Rep. 10(1):19817, 2020, IF:4.380 / CI:8. 31. Inomata T (Corresponding Author), Iwagami M, Nakamura M, Shiang T, Fujimoto K, Okumura Y, Iwata N, Fujio K, Hiratsuka Y, Hori S, Tsubota K, Dana R, Murakami A: Association between dry eye and depressive symptoms: Large-scale crowdsourced research using the DryEyeRhythm iPhone application. Ocul Surf. 18(2):312-9, 2020, IF:5.033 /CI:18. 32. Inomata T (Corresponding Author), Iwagami M, Nakamura M, Shiang T, Yoshimura Y, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Hori S, Hiratsuka Y, Uchino M, Tsubota K, Dana R, Murakami A: Characteristics and Risk Factors Associated With Diagnosed and Undiagnosed Symptomatic Dry Eye Using a Smartphone Application. JAMA Ophthalmol. 138(1):58-68, 2020, IF:7.389 / CI:35. 33. Inomata T (Corresponding Author), Kitazawa K, Kuno T, Sung J, Nakamura M, Iwagami M, Takagi H, Midorikawa-Inomata A, Zhu J, Fujimoto K, Okumura Y, Miura M, Fujio K, Hirosawa K, Akasaki Y, Kuwahara M, Dana R, Murakami A: Clinical and Prodromal Ocular Symptoms in Coronavirus Disease: A Systematic Review and Meta-Analysis. Invest Ophthalmol Vis Sci. 61(10):29, 2020, IF:4.799 /CI:42. 34. Inomata T (Corresponding Author), Nakamura M, Iwagami M, Midorikawa-Inomata A, Okumura Y, Fujimoto K, Iwata N, Eguchi A, Shokirova H, Miura M, Fujio K, Nagino K, Nojiri S, Murakami A: Comparing the Japanese Version of the Ocular Surface Disease Index and Dry Eye-Related Quality-of-Life Score for Dry Eye Symptom Assessment. Diagnostics (Basel). 10(4), 2020, IF:3.706 / CI:4. 35. Inomata T (Corresponding Author), Nakamura M, Iwagami M, Midorikawa-Inomata A, Sung J, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Fujio K, Nagino K, Hori S, Tsubota K, Dana R, Murakami A: Stratification of Individual Symptoms of Contact Lens-Associated Dry Eye Using the iPhone App DryEyeRhythm: Crowdsourced Cross-Sectional Study. J Med Internet Res. 22(6):e18996, 2020, IF:5.428 / CI:7. 36. Inomata T (Corresponding Author), Sung J, Nakamura M, Iwagami M, Okumura Y, Iwata N, Midorikawa-Inomata A, Fujimoto K, Eguchi A, Nagino K, Fujio K, Miura M, Shokirova H, Murakami A: Using Medical Big Data to Develop Personalized Medicine for Dry Eye Disease. Cornea. 39 Suppl 1:S39-s46, 2020, IF:2.651 / CI:6. 37. Koiwa C, Nakatani S, Inomata T (Corresponding Author), Yamaguchi M, Iwamoto S, Murakami A: Multiple excimer laser phototherapeutic keratectomies for Avellino corneal dystrophy: a case report. Int J Ophthalmol. 13(5):841-4, 2020, IF:1.779 / CI:2. 38. Eguchi A, Inomata T (Corresponding Author), Nakamura M, Nagino K, Iwagami M, Sung J, Midorikawa-Inomata A, Okumura Y, Fujio K, Fujimoto K, Miura M, Akasaki Y, Shokirova H, Hirosawa K, Kuwahara M, Zhu J, Dana R, Murakami A, Kobayashi H: Heterogeneity of eye drop use among symptomatic dry eye individuals in Japan: large-scale crowdsourced research using DryEyeRhythm application. Jpn J Ophthalmol. 65(2):271-81, 2021, IF:2.447 / CI:6. 39. Fujimoto K, Uchida K, Yin E, Zhu J, Kojima Y, Uchiyama M, Yamamoto Y, Bashuda H, Matsumoto R, Tokushige K, Harada M, Inomata T, Kitaura J, Murakami A, Okumura K, Takeda K: Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation. Transplant immunology.101405, 2021, IF:1.708 / CI:1. 40. Inomata T (Corresponding Author), Nakamura M, Iwagami M, Sung J, Nakamura M, Ebihara N, Fujisawa K, Muto K, Nojiri S, Ide T, Okano M, Okumura Y, Fujio K, Fujimoto K, Nagao M, Hirosawa K, Akasaki Y, Murakami A: Symptom-based stratification for hay fever: A crowdsourced study using the smartphone application AllerSearch. Allergy. 76(12):3820-4, 2021, IF:13.146 / CI:2. 41. Inomata T (Corresponding Author), Nakamura M, Sung J, Midorikawa-Inomata A, Iwagami M, Fujio K, Akasaki Y, Okumura Y, Fujimoto K, Eguchi A, Miura M, Nagino K, Shokirova H, Zhu J, Kuwahara M, Hirosawa K, Dana R, Murakami A: Smartphone-based digital phenotyping for dry eye toward P4 medicine: a crowdsourced cross-sectional study. NPJ Digit Med. 4(1):171, 2021, IF:11.653 / CI:–. 42. Shokirova H, Inomata T (Corresponding Author), Saitoh T, Zhu J, Fujio K, Okumura Y, Yanagawa A, Fujimoto K, Sung J, Eguchi A, Miura M, Nagino K, Hirosawa K, Kuwahara M, Akasaki Y, Nagase H, Murakami A: Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation. Sci Rep. 11(1):8647, 2021, IF:4.380 / CI:3. 43. Zhu J, Inomata T (Corresponding Author), Di Zazzo A, Kitazawa K, Okumura Y, Coassin M, Surico PL, Fujio K, Yanagawa A, Miura M, Akasaki Y, Fujimoto K, Nagino K, Midorikawa-Inomata A, Hirosawa K, Kuwahara M, Huang T, Shokirova H, Eguchi A, Murakami A: Role of Immune Cell Diversity and Heterogeneity in Corneal Graft Survival: A Systematic Review and Meta-Analysis. J Clin Med. 10(20), 2021, IF:4.242 / CI:1. 44. Zhu J, Inomata T (Corresponding Author), Fujimoto K, Uchida K, Fujio K, Nagino K, Miura M, Negishi N, Okumura Y, Akasaki Y, Hirosawa K, Kuwahara M, Eguchi A, Shokirova H, Yanagawa A, Midorikawa-Inomata A, Murakami A: Ex Vivo-Induced Bone Marrow-Derived Myeloid Suppressor Cells Prevent Corneal Allograft Rejection in Mice. Invest Ophthalmol Vis Sci. 62(7):3, 2021, IF:4.799 /CI:5. 45. Adachi T, Ogawa Y, Fukushi T, Ito K, Koizumi A, Shirabe M, Toriya M, Hirako J, Inomata T, Masaki K, Sasano R, Sato S, Kainuma K, Futamura M, Kan OK, Kurashima Y, Nakajima S, Sakashita M, Morita H, Iwamoto A, Nishima S, Tamari M, Iizuka H: Research impact analysis of international funding agencies in the realm of allergy and immunology. Allergy. 2022, IF:13.146 / CI:0. 46. Inomata T (Corresponding Author), Nakamura M, Iwagami M, Sung J, Nakamura M, Ebihara N, Fujisawa K, Muto K, Nojiri S, Ide T, Okano M, Okumura Y, Fujio K, Fujimoto K, Nagao M, Hirosawa K, Akasaki Y, Murakami A: Individual characteristics and associated factors of hay fever: A large-scale mHealth study using AllerSearch. Allergol Int. 2022, IF:5.836 / CI:0. 47. Miura M, Inomata T (Corresponding Author), Nojiri S, Sung J, Nagao M, Shimazaki J, Midorikawa-Inomata A, Okumura Y, Fujio K, Akasaki Y, Kuwahara M, Huang T, Nakamura M, Iwagami M, Hirosawa K, Fujimoto K, Murakami A: Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery: a protocol for a single-centre, randomised controlled trial. BMJ Open. 12(1):e052488, 2022, IF:2.692 /CI:0. 48. Rhee J, Chan TC, Chow SS, Di Zazzo A, Inomata T, Shih KC, Tong L: A Systematic Review on the Association Between Tear Film Metrics and Higher Order Aberrations in Dry Eye Disease and Treatment. Ophthalmol Ther. 11(1):35-67, 2022, IF:3.536 /CI:1. 49. Sato S, Kainuma K, Noda T, Ebisawa M, Futamura M, Imamura T, Miyagawa A, Nakajima S, Ogawa Y, Inomata T, Kan OK, Kurashima Y, Masaki K, Myojin T, Nishioka Y, Sakashita M, Tamari M, Morita H, Adachi T: Evaluation of adrenaline auto-injector prescription profiles: A population-based, retrospective cohort study within the National Insurance Claims Database of Japan. Allergol Int. 2022, IF:5.836 / CI:0. 50. Zhu J, Inomata T (Corresponding Author), Nakamura M, Fujimoto K, Akasaki Y, Fujio K, Yanagawa A, Uchida K, Sung J, Negishi N, Nagino K, Okumura Y, Miura M, Shokirova H, Kuwahara M, Hirosawa K, Midorikawa-Inomata A, Eguchi A, Huang T, Yagita H, Habu S, Okumura K, Murakami A: Anti-CD80/86 antibodies inhibit inflammatory reaction and improve graft survival in a high-risk murine corneal transplantation rejection model. Sci Rep. 12(1):4853, 2022, IF:4.380 / CI:0. 51. Okumura Y, Inomata T (Corresponding Author), Midorikawa-Inomata A, Sung J, Fujio K, Akasaki Y, Nakamura M, Iwagami M, Fujimoto K, Eguchi A, Miura M, Nagino K, Hirosawa K, Huang T, Kuwahara M, Dana R, Murakami A: DryEyeRhythm: A reliable and valid smartphone application for dry eye diagnosis. Ocul Surf. 2022, in press, IF:5.033 /CI:0. 52. Miura M, Inomata T (Corresponding Author), Nakamura M, Sung J, Nagino K, Midorikawa-Inomata A, Zhu J, Fujimoto K, Okumura Y, Fujio K, Hirosawa K, Akasaki Y, Kuwahara M, Eguchi A, Shokirova H, Murakami A: Prevalence and characteristics of dry eye disease after cataract surgery: A systematic review and meta-analysis. Ophthalmol Ther. 2022, in press, IF:3.536 /CI:0. 「和文原著【総数１１編・筆頭著者数４編・責任著者(corresponding author)数５編】」 1. 猪俣武範、済陽里佳、藤巻拓郎、小野浩一、中谷智、福村由紀、梅田裕祥、海老原伸行、村上晶: 虹彩全幅切除を併用した先天虹彩嚢胞の一例. 眼臨紀. 3:390-3, 2010. 2. 小野浩一、平塚義宗、田野貴俊、猪俣武範: 南会津・只見町コホート研究：網膜血管径とメタボリックシンドロームの疫学. 順天堂医学. 56:360, 2010. 3. 井上亮, 猪俣武範, 田村薫, 林誠一郎, 横山利幸, 晶村: ベバシズマブ硝子体注入を併用した23ゲージ硝子体手術の検討. 臨床眼科. 64:863-7, 2010 4. 猪俣武範、武田淳史、本田理峰、松井麻紀、土至田宏、太田俊彦、小池道明、矢田清身、村上晶: ガンシクロビルの点滴と点眼が奏効したサイトメガロウイルス角膜内皮炎の1例. 臨床眼科. 65:875-9, 2011. 5. 宮本静華, 猪俣武範 (責任著者), 中谷智, 平塚義宗, 村上晶: アイバンク提供眼の眼球保存液におけるMRSA汚染の検討. 臨床眼科. 71(10):1549-55, 2017. 6. 水野樹, 稲田英一, 猪俣武範, 嶋田晶江, 川崎志保理, 天野篤, 吉川努, 国松修一: 手術の術前時間と術後時間の長さ : 外科系診療科と麻酔法による差. 臨床麻酔. 41(10):1411-5, 2017. 7. 水野樹, 稲田英一, 猪俣武範, 吉川努, 国松修一.: 全身麻酔下に施行された脳神経外科手術における術前時間、手術時間、術後時間. 麻酔. 67(12):1264-8, 2018. 8. 猪俣武範 (責任著者): ResearchKitを用いて作成したiPhoneアプリケーション「ドライアイリズム」によるドライアイの啓発と新しい大規模臨床研究. あたらしい眼科. 35(7), 2018. 9. 水野樹, 猪俣武範 (責任著者): ラテックス製手術用手袋の熱老化特性. 手術医学. 40(3):153-7, 2019. 10. 藤尾健太, 猪俣武範 (責任著者), 中村正裕, 岩上将夫, 海老原伸行, 中村真浩, 藤澤空見子, 武藤香織, 岡野光博, 奥村雄一, 井手拓磨, 野尻宗子, 赤崎安序, 長尾雅史, 藤本啓一, 村上晶: 患者・市民参画を取り入れた花粉症用スマートフォンアプリケーション”アレルサーチ”による双方向性研究実現に向けた研究. 臨眼. 75(10):1328-37, 2021. 11. 猪俣武範 (責任著者): 花粉症の多様な症状の層別化〜患者・市民参画を取り入れたスマホアプリを用いたクラウド型大規模横断観察研究. Allos ergon. 1(3):347-55, 2021. 「英文総説【総数10編・筆頭著者数4編・責任著者(corresponding author)数5編】」 1. Inomata T (Corresponding Author): A New Immunotherapy Using Regulatory T-Cells for High-Risk Corneal Transplantation. Juntendo Medical Journal. 63(1):2-7, 2017, IF: – / CI:5. 2. Tahvildari M, Inomata T (Co-1st Author), Amouzegar A, Dana R: Regulatory T cell modulation of cytokine and cellular networks in corneal graft rejection. Curr Ophthalmol Rep. 6(4):266-74, 2018, IF: – / CI:11. 3. Heidari M, Noorizadeh F, Wu K, Inomata T (Co-Last Author), Mashaghi A: Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy. J Clin Med. 8(9), 2019, IF: 4.242 / CI:32. 4. Di Zazzo A, Lee S-M, Sung J, Niutta M, Coassin M, Mashaghi A, Inomata T (Last Author): Variable Responses to Corneal Grafts: Insights from Immunology and Systems Biology. J Clin Med. 9(2), 2020, IF:4.242 / CI:11. 5. Inomata T (Corresponding Author), Sung J, Nakamura M, Fujisawa K, Muto K, Ebihara N, Iwagami M, Nakamura M, Fujio K, Okumura Y, Okano M, Murakami A: New medical big data for P4 medicine on allergic conjunctivitis. Allergol Int. 69(4):510-8, 2020, IF:5.836 / CI:15. 6. Okumura Y, Inomata T (Corresponding Author), Iwata N, Sung J, Fujimoto K, Fujio K, Midorikawa-Inomata A, Miura M, Akasaki Y, Murakami A: A Review of Dry Eye Questionnaires: Measuring Patient-Reported Outcomes and Health-Related Quality of Life. Diagnostics (Basel). 10(8), 2020, IF:3.706 / CI:26. 7. Grasso A, Di Zazzo A, Giannaccare G, Sung J, Inomata T, Shih KC, Micera A, Gaudenzi D, Spelta S, Romeo MA, Orsaria P, Coassin M, Altomare V: Sex Hormones Related Ocular Dryness in Breast Cancer Women. J Clin Med. 10(12), 2021, IF:4.242 / CI:3. 8. Inomata T (Corresponding Author), Sung J, Nakamura M, Iwagami M, Okumura Y, Fujio K, Akasaki Y, Fujimoto K, Yanagawa AI, Midorikawa-Inomata A, Nagino K, Eguchi A, Shokirova H, Zhu J, Miura M, Kuwahara M, Hirosawa K, Huang T, Morooka Y, Murakami A: Cross-hierarchical Integrative Research Network for Heterogenetic Eye Disease Toward P4 Medicine: A Narrative Review. Juntendo Medical Journal. advpub, 2021, IF: – / CI:0. 9. Kitazawa K, Deinhardt-Emmer S, Inomata T, Deshpande S, Sotozono C: The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies. Cells. 10(4), 2021, IF: 6.600 / CI:6. 10. Zhu J, Inomata T (Corresponding Author), Shih KC, Okumura Y, Fujio K, Huang T, Nagino K, Akasaki Y, Fujimoto K, Yanagawa A, Miura M, Midorikawa-Inomata A, Hirosawa K, Kuwahara M, Shokirova H, Eguchi A, Morooka Y, Chen F, Murakami A: Application of Animal Models in Interpreting Dry Eye Disease. Front Med (Lausanne). 9:830592, 2022, IF: 5.093 / CI:0. 「和文総説【総数２０編・筆頭著者数1８編・責任著者(corresponding author)数1８編】」 1. 猪俣武範 (責任著者): 世界のドライアイの考え方の比較. あたらしい眼科. 34(3):371-80, 2017. 2. 猪俣武範 (責任著者): コンタクトレンズ関連ドライアイ. 日本コンタクトレンズ学会誌. 59(3):177, 2017. 3. 猪俣武範、本田美樹: 硝子体注射の日米ガイドラインの比較. 眼科手術. 30:5-11, 2017. 4. 猪俣武範 (責任著者): 制御性T細胞(Treg)について. あたらしい眼科. 35(9):1255, 2018. 5. 猪俣武範 (責任著者): IoMTは医療をどう変えるか〜医療におけるデジタルユビキティへの変革〜. Journal of Internet of Medical Things. 1(1):4-9, 2018. 6. 奥村雄一, 猪俣武範 (責任著者): HEMA (2-hydroxyethyl methacrylate). 日本コンタクトレンズ学会誌. 61(1), 2019. 7. 猪俣武範 (責任著者): ResearchKitを用いたアプリケーションによる新しい医療ビッグデータの可能性. Journal of Internet of Medical Things. 2(1):10-5, 2019. 8. 猪俣武範 (責任著者): 新しい医療ビッグデータとドライアイ. Frontiers in Dry Eye. 14(1):16-9, 2019. 9. 猪俣武範 (責任著者): 新しい医療ビッグデータによる医療のパラダイムシフト. 保健の科学. 62(1):4-9, 2020. 10. 猪俣武範 (責任著者): モバイルヘルスによるP4 Medicineの実現. 眼科グラフィック. 9:532-7, 2020. 11. 猪俣武範 (責任著者): 令和元年度日本眼科学会学術奨励賞受賞論文総説, モバイルヘルスを利用した医療ビッグデータ解析による個別化医療の実現：iPhoneアプリケーション「ドライアイリズムⓇ」を用いたクラウド型大規模臨床研究. 日眼会誌. 124(11):861-72, 2020. 12. 猪俣武範 (責任著者): スマホアプリで収集した医療ビッグデータ解析によるドライアイのP4 Medicine実現のための研究. 「研究成果を社会へ」人生100年時代を見据えた運動の生活カルチャー化への挑戦. Active. 6:15, 2020. 13. 村上晶, 藤巻拓郎, 舟木俊成, 山口昌大, 川村雄一, 藤木慶子, 岩田文乃, 平形寿彬, 平塚義宗, 土至田宏，小野浩一, 中谷智, 太田俊彦, 猪俣武範, 松田彰, 海老原伸行, 横山利幸, 早川むつ子: 眼科遺伝学― 分子遺伝学と難治性眼疾患治療への展開―. 日眼会誌. 125(3):210-29, 2021 14. 猪俣武範 (責任著者): モバイルヘルスから収集した医療ビッグデータを用いたデータ駆動型解析によるドライアイに対するP4 Medicineの実現. 日本の眼科. 92(1), 2021. 15. 猪俣武範 (責任著者): 患者の主観的な指標に基づく多様なドライアイ症状の定量化による予測・予防・個別化医療の実現. 日本の眼科. 92(2):141-2, 2021. 16. 猪俣武範 (責任著者): スマホアプリを用いたドライアイ未診断者の特徴の解明. Frontiers in Dry Eye. 16(1):30-1, 2021. 17. 猪俣武範 (責任著者): ドライアイ用スマホアプリによる新しい医療ビッグデータの収集 P4 Medicineの実現に向けて. medicina. 58(6):850-4, 2021. 18. 猪俣武範 (責任著者): モバイルヘルスアプリを利用した花粉症に対するP4 Medicineに基づくヒト中心のユビキタス医療の実現. アレルギーの臨床. 41(8):717-22, 2021. 19. 猪俣武範 (責任著者): Society5.0時代の医療. Journal of Internet of Medical Things. 4(1):4-7, 2021. 20. 猪俣武範 (責任著者): 第43回(令和2年度)順天堂大学医学部同窓会学術奨励賞抄録データ駆動型多階層横断的研究による眼疾患に対する「P4 Medicine」の実現. 茶崖. 182:47, 2021. 「英文著書」該当なし「和文著書」 1. 猪俣武範. ハーバード×MBA×医師目標を次々に達成する人の最強の勉強法: ディスカヴァー・トゥエンティワン; 2016. 2. 猪俣武範. ハーバード×MBA×医師働く人のための最強の休息法: ディスカヴァー・トゥエンティワン; 2017. 3. 猪俣武範、中尾武史. ハーバード大学眼科イラストレイテッドマニュアル: 金原出版; 2017. 4. IoMT学会編集委員会. IoMTの可能性と未来. In: 猪俣武範, editor. Journal of Internet of Medical Things. 1. 東京: メディカルレビュー; 2018. 5. IoMT学会編集委員会. IoMTのUP-TO-DATE. In: 猪俣武範, editor. Journal of Internet of Medical Things. 2. 東京: メディカルレビュー; 2019. 6. 猪俣武範, 松尾剛行. 医者と弁護士が知っている日本の病院 7つのなぜ: クロスメディア・パブリッシング(インプレス); 2019. 7. スマホと眼 Pros & Cons. 猪俣武範, editor: 全日本病院出版会; 2020. 8. IoMT学会編集委員会. IoMTのエコシステム./New insights of IoMT. In: 猪俣武範, editor. Journal of Internet of Medical Things. 3. 東京: メディカルレビュー; 2020. 9. IoMT学会編集委員会. インフラ化するIoMT. 猪俣武範, editor: メディカルレビュー; 2021. 10. 一般社団法人日本医療戦略研究センター(J-SMARC). 戦略的医療マネジメント―VUCA時代を乗り切るMBA視点: 中外医学社; 2021.

研究テーマ

眼科一般、角膜、角膜移植、免疫、炎症、ドライアイ、虹彩、疫学、網膜、経営、リーダーシップ、IoT、IoMT、AI

研究業績（論文）

「英文原著【総数52編・筆頭著者数22編・責任著者(corresponding author)数32編】」
1. Inomata T, Ebihara N, Funaki T, Matsuda A, Watanabe Y, Ning L, Xu Z, Murakami A, Arikawa-Hirasawa E: Perlecan-deficient mutation impairs corneal epithelial structure. Invest Ophthalmol Vis Sci. 53(3):1277-84, 2012, IF:4.799 / CI:38.
2. Hua J, Jin Y, Chen Y, Inomata T, Lee H, Chauhan SK, Petasis NA, Serhan CN, Dana R: The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation. Invest Ophthalmol Vis Sci. 55(9):5944-51, 2014, IF:4.799 / CI:49.
3. Inomata T, Mashaghi A, Di Zazzo A, Dana R: Ocular surgical models for immune and angiogenic responses. J Biol Methods. 2(3), 2015, IF:– /CI:26.
4. Xu J, Hong J, Sun X, Liu Z, Mashaghi A, Inomata T, Lu Y, Li Y, Wu D, Yang Y, Wei A, Zhao Y, Lu C: Combined Lacrimal Passage Probing and Tobramycin/Dexamethasone Ophthalmic Ointment Infiltration: A Minimally Invasive Surgical Procedure for Incomplete Nasolacrimal Duct Obstruction. Medicine (Baltimore). 94(36):e1483, 2015, IF:1.889 / CI:7.
5. Hua J, Stevenson W, Dohlman TH, Inomata T, Tahvildari M, Calcagno N, Pirmadjid N, Sadrai Z, Chauhan SK, Dana R: Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis. Invest Ophthalmol Vis Sci. 57(3):1457-67, 2016, IF:4.799 /CI:25.
6. Inomata T (Corresponding Author), Honda M, Murakami A: Atypical VZV Retinitis in a Patient with Good Syndrome. Ocul Immunol Inflamm.1-5, 2016, IF:3.070 /CI:6.
7. Inomata T, Hua J, Di Zazzo A, Dana R: Impaired Function of Peripherally Induced Regulatory T Cells in Hosts at High Risk of Graft Rejection. Sci Rep. 6:39924, 2016, IF:4.380 / CI:36.
8. Tahvildari M, Omoto M, Chen Y, Emami-Naeini P, Inomata T, Dohlman TH, Kaye AE, Chauhan SK, Dana R: In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation. Transplantation. 100(3):525-32, 2016, IF:4.939 / CI:71.
9. Chen Y, Chauhan SK, Shao C, Omoto M, Inomata T, Dana R: IFN-gamma-Expressing Th17 Cells Are Required for Development of Severe Ocular Surface Autoimmunity. Journal of immunology. 199(3):1163-9, 2017, IF:5.422 / CI:59.
10. Di Zazzo A, Tahvildari M, Subbarayal B, Yin J, Dohlman TH, Inomata T, Mashaghi A, Chauhan SK, Dana R: Proangiogenic Function of T Cells in Corneal Transplantation. Transplantation. 101(4):778-85, 2017, IF:4.939 / CI:22.
11. Inomata T, Mashaghi A, Di Zazzo A, Lee SM, Chiang H, Dana R: Kinetics of Angiogenic Responses in Corneal Transplantation. Cornea. 36(4):491-6, 2017, IF:2.651 / CI:29.
12. Inomata T, Mashaghi A, Hong J, Nakao T, Dana R: Scaling and maintenance of corneal thickness during aging. PloS one. 12(10):e0185694, 2017, IF:3.240 / CI:13.
13. Inomata T (Corresponding Author), Ono K, Matsuba T, Shiang T, Di Zazzo A, Nakatani S, Yamaguchi M, Ebihara N, Murakami A: Pre-banking microbial contamination of donor conjunctiva and storage medium for penetrating keratoplasty. Jpn J Ophthalmol. 61(5):369-77, 2017, IF:2.447 / CI:5.
14. Qi H, Chen Y, Inomata T, Amouzegar A, Dana R: IL-10-Producing Th17 Cells: A Potentially Regulatory Cell Population in Dry Eye Disease. Journal of Immunology and Immunotherapy. 2(1:5), 2017, IF:0.33 / CI3.
15. Hua J, Inomata T, Chen Y, Foulsham W, Stevenson W, Shiang T, Bluestone JA, Dana R: Pathological conversion of regulatory T cells is associated with loss of allotolerance. Sci Rep. 8(1):7059, 2018, IF:4.380 / CI:65.
16. Inomata T, Hua J, Nakao T, Shiang T, Chiang H, Amouzegar A, Dana R: Corneal Tissue From Dry Eye Donors Leads to Enhanced Graft Rejection. Cornea. 37(1):95-101, 2018, IF:2.651 / CI:20.
17. Inomata T (Corresponding Author), Iwagami M, Hiratsuka Y, Fujimoto K, Okumura Y, Shiang T, Murakami A: Maximum blink interval is associated with tear film breakup time: A new simple, screening test for dry eye disease. Sci Rep. 8(1):13443, 2018, IF:4.380 / CI:7.
18. Inomata T (Corresponding Author), Mizuno J, Iwagami M, Kawasaki S, Shimada A, Inada E, Shiang T, Amano A: The impact of Joint Commission International accreditation on time periods in the operating room: A retrospective observational study. PloS one. 13(9):e0204301, 2018, IF:3.240 / CI:18.
19. Inomata T (Corresponding Author), Shiang T, Iwagami M, Sakemi F, Fujimoto K, Okumura Y, Ohno M, Murakami A: Changes in Distribution of Dry Eye Disease by the New 2016 Diagnostic Criteria from the Asia Dry Eye Society. Sci Rep. 8(1):1918, 2018, IF:4.380 / CI:27.
20. Ogawa M, Inomata T (Corresponding Author), Shiang T, Tsubota K, Murakami A: Method for selective quantification of immune and inflammatory cells in the cornea using flow cytometry. J Biol Methods. 5(4):e102, 2018, IF: – /CI:9.
21. Takei M, Obana A, Inomata T (Corresponding Author), Tanaka T, Shiang T, Bae Y, Takemura T, Murakami A: Fundus changes in type III membranoproliferative glomerulonephritis: a case report. BMC Ophthalmol. 18(1):72, 2018, IF:2.209 / CI:5.
22. Tan X, Chen Y, Foulsham W, Amouzegar A, Inomata T, Liu Y, Chauhan SK, Dana R: The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease. Ocul Surf. 2018, IF:5.033 /CI:21.
23. Inomata T (Corresponding Author), Nakamura M, Iwagami M, Shiang T, Yoshimura Y, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Hori S, Hiratsuka Y, Uchino M, Tsubota K, Dana R, Murakami A: Risk Factors for Severe Dry Eye Disease: Crowdsourced Research Using DryEyeRhythm. Ophthalmology. 126(5):766-8, 2019, IF:12.079 /CI:22.
24. Midorikawa-Inomata A, Inomata T (Corresponding Author), Nojiri S, Nakamura M, Iwagami M, Fujimoto K, Okumura Y, Iwata N, Eguchi A, Hasegawa H, Kinouchi H, Murakami A, Kobayashi H: Reliability and validity of the Japanese version of the Ocular Surface Disease Index for dry eye disease. BMJ Open. 9(11):e033940, 2019, IF:2.692 /CI:24.
25. Muto T, Nishimura T, Sakamoto M, Inomata T, Machida S: Identification of eyes at risk of acute primary angle-closure in elderly Japanese patients. Clin Ophthalmol. 13:859-68, 2019, IF:0.77 /CI:3.
26. Okumura Y, Inomata T (Corresponding Author), Iwagami M, Eguchi A, Mizuno J, Shiang T, Kawasaki S, Shimada A, Inada E, Amano A, Murakami A: Shortened cataract surgery by standardisation of the perioperative protocol according to the Joint Commission International accreditation: a retrospective observational study. BMJ Open. 9(6):e028656, 2019, IF:2.692 /CI:5.
27. Okumura Y, Inomata T (Corresponding Author), Miyamoto S, Nakatani S, Hiratsuka Y, Yamaguchi M, Iwamoto S, Murakami A: Donor Characteristics and Risk Factors for Methicillin-Resistant Staphylococcus aureus Contamination in Storage Medium for Corneal Transplantation: A 10-year Retrospective Study. Transpl Infect Dis.e13123, 2019, IF:2.228 /CI:3.
28. Fujimoto K, Inomata T (Corresponding Author), Okumura Y, Iwata N, Fujio K, Eguchi A, Nagino K, Shokirova H, Karasawa M, Murakami A: Comparison of corneal thickness in patients with dry eye disease using the Pentacam rotating Scheimpflug camera and anterior segment optical coherence tomography. PloS one. 15(2), 2020, IF:3.240 / CI:5.
29. Hirosawa K, Inomata T (Corresponding Author), Sung J, Nakamura M, Okumura Y, Midorikawa-Inomata A, Miura M, Fujio K, Akasaki Y, Fujimoto K, Zhu J, Eguchi A, Nagino K, Kuwahara M, Shokirova H, Yanagawa A, Murakami A: Diagnostic ability of maximum blink interval together with Japanese version of Ocular Surface Disease Index score for dry eye disease. Sci Rep. 10(1):18106, 2020, IF:4.380 / CI:7.
30. Inomata T (Corresponding Author), Fujimoto K, Okumura Y, Zhu J, Fujio K, Shokirova H, Miura M, Okano M, Funaki T, Sung J, Negishi N, Murakami A: Novel immunotherapeutic effects of topically administered ripasudil (K-115) on corneal allograft survival. Sci Rep. 10(1):19817, 2020, IF:4.380 / CI:8.
31. Inomata T (Corresponding Author), Iwagami M, Nakamura M, Shiang T, Fujimoto K, Okumura Y, Iwata N, Fujio K, Hiratsuka Y, Hori S, Tsubota K, Dana R, Murakami A: Association between dry eye and depressive symptoms: Large-scale crowdsourced research using the DryEyeRhythm iPhone application. Ocul Surf. 18(2):312-9, 2020, IF:5.033 /CI:18.
32. Inomata T (Corresponding Author), Iwagami M, Nakamura M, Shiang T, Yoshimura Y, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Hori S, Hiratsuka Y, Uchino M, Tsubota K, Dana R, Murakami A: Characteristics and Risk Factors Associated With Diagnosed and Undiagnosed Symptomatic Dry Eye Using a Smartphone Application. JAMA Ophthalmol. 138(1):58-68, 2020, IF:7.389 / CI:35.
33. Inomata T (Corresponding Author), Kitazawa K, Kuno T, Sung J, Nakamura M, Iwagami M, Takagi H, Midorikawa-Inomata A, Zhu J, Fujimoto K, Okumura Y, Miura M, Fujio K, Hirosawa K, Akasaki Y, Kuwahara M, Dana R, Murakami A: Clinical and Prodromal Ocular Symptoms in Coronavirus Disease: A Systematic Review and Meta-Analysis. Invest Ophthalmol Vis Sci. 61(10):29, 2020, IF:4.799 /CI:42.
34. Inomata T (Corresponding Author), Nakamura M, Iwagami M, Midorikawa-Inomata A, Okumura Y, Fujimoto K, Iwata N, Eguchi A, Shokirova H, Miura M, Fujio K, Nagino K, Nojiri S, Murakami A: Comparing the Japanese Version of the Ocular Surface Disease Index and Dry Eye-Related Quality-of-Life Score for Dry Eye Symptom Assessment. Diagnostics (Basel). 10(4), 2020, IF:3.706 / CI:4.
35. Inomata T (Corresponding Author), Nakamura M, Iwagami M, Midorikawa-Inomata A, Sung J, Fujimoto K, Okumura Y, Eguchi A, Iwata N, Miura M, Fujio K, Nagino K, Hori S, Tsubota K, Dana R, Murakami A: Stratification of Individual Symptoms of Contact Lens-Associated Dry Eye Using the iPhone App DryEyeRhythm: Crowdsourced Cross-Sectional Study. J Med Internet Res. 22(6):e18996, 2020, IF:5.428 / CI:7.
36. Inomata T (Corresponding Author), Sung J, Nakamura M, Iwagami M, Okumura Y, Iwata N, Midorikawa-Inomata A, Fujimoto K, Eguchi A, Nagino K, Fujio K, Miura M, Shokirova H, Murakami A: Using Medical Big Data to Develop Personalized Medicine for Dry Eye Disease. Cornea. 39 Suppl 1:S39-s46, 2020, IF:2.651 / CI:6.
37. Koiwa C, Nakatani S, Inomata T (Corresponding Author), Yamaguchi M, Iwamoto S, Murakami A: Multiple excimer laser phototherapeutic keratectomies for Avellino corneal dystrophy: a case report. Int J Ophthalmol. 13(5):841-4, 2020, IF:1.779 / CI:2.
38. Eguchi A, Inomata T (Corresponding Author), Nakamura M, Nagino K, Iwagami M, Sung J, Midorikawa-Inomata A, Okumura Y, Fujio K, Fujimoto K, Miura M, Akasaki Y, Shokirova H, Hirosawa K, Kuwahara M, Zhu J, Dana R, Murakami A, Kobayashi H: Heterogeneity of eye drop use among symptomatic dry eye individuals in Japan: large-scale crowdsourced research using DryEyeRhythm application. Jpn J Ophthalmol. 65(2):271-81, 2021, IF:2.447 / CI:6.
39. Fujimoto K, Uchida K, Yin E, Zhu J, Kojima Y, Uchiyama M, Yamamoto Y, Bashuda H, Matsumoto R, Tokushige K, Harada M, Inomata T, Kitaura J, Murakami A, Okumura K, Takeda K: Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation. Transplant immunology.101405, 2021, IF:1.708 / CI:1.
40. Inomata T (Corresponding Author), Nakamura M, Iwagami M, Sung J, Nakamura M, Ebihara N, Fujisawa K, Muto K, Nojiri S, Ide T, Okano M, Okumura Y, Fujio K, Fujimoto K, Nagao M, Hirosawa K, Akasaki Y, Murakami A: Symptom-based stratification for hay fever: A crowdsourced study using the smartphone application AllerSearch. Allergy. 76(12):3820-4, 2021, IF:13.146 / CI:2.
41. Inomata T (Corresponding Author), Nakamura M, Sung J, Midorikawa-Inomata A, Iwagami M, Fujio K, Akasaki Y, Okumura Y, Fujimoto K, Eguchi A, Miura M, Nagino K, Shokirova H, Zhu J, Kuwahara M, Hirosawa K, Dana R, Murakami A: Smartphone-based digital phenotyping for dry eye toward P4 medicine: a crowdsourced cross-sectional study. NPJ Digit Med. 4(1):171, 2021, IF:11.653 / CI:–.
42. Shokirova H, Inomata T (Corresponding Author), Saitoh T, Zhu J, Fujio K, Okumura Y, Yanagawa A, Fujimoto K, Sung J, Eguchi A, Miura M, Nagino K, Hirosawa K, Kuwahara M, Akasaki Y, Nagase H, Murakami A: Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation. Sci Rep. 11(1):8647, 2021, IF:4.380 / CI:3.
43. Zhu J, Inomata T (Corresponding Author), Di Zazzo A, Kitazawa K, Okumura Y, Coassin M, Surico PL, Fujio K, Yanagawa A, Miura M, Akasaki Y, Fujimoto K, Nagino K, Midorikawa-Inomata A, Hirosawa K, Kuwahara M, Huang T, Shokirova H, Eguchi A, Murakami A: Role of Immune Cell Diversity and Heterogeneity in Corneal Graft Survival: A Systematic Review and Meta-Analysis. J Clin Med. 10(20), 2021, IF:4.242 / CI:1.
44. Zhu J, Inomata T (Corresponding Author), Fujimoto K, Uchida K, Fujio K, Nagino K, Miura M, Negishi N, Okumura Y, Akasaki Y, Hirosawa K, Kuwahara M, Eguchi A, Shokirova H, Yanagawa A, Midorikawa-Inomata A, Murakami A: Ex Vivo-Induced Bone Marrow-Derived Myeloid Suppressor Cells Prevent Corneal Allograft Rejection in Mice. Invest Ophthalmol Vis Sci. 62(7):3, 2021, IF:4.799 /CI:5.
45. Adachi T, Ogawa Y, Fukushi T, Ito K, Koizumi A, Shirabe M, Toriya M, Hirako J, Inomata T, Masaki K, Sasano R, Sato S, Kainuma K, Futamura M, Kan OK, Kurashima Y, Nakajima S, Sakashita M, Morita H, Iwamoto A, Nishima S, Tamari M, Iizuka H: Research impact analysis of international funding agencies in the realm of allergy and immunology. Allergy. 2022, IF:13.146 / CI:0.
46. Inomata T (Corresponding Author), Nakamura M, Iwagami M, Sung J, Nakamura M, Ebihara N, Fujisawa K, Muto K, Nojiri S, Ide T, Okano M, Okumura Y, Fujio K, Fujimoto K, Nagao M, Hirosawa K, Akasaki Y, Murakami A: Individual characteristics and associated factors of hay fever: A large-scale mHealth study using AllerSearch. Allergol Int. 2022, IF:5.836 / CI:0.
47. Miura M, Inomata T (Corresponding Author), Nojiri S, Sung J, Nagao M, Shimazaki J, Midorikawa-Inomata A, Okumura Y, Fujio K, Akasaki Y, Kuwahara M, Huang T, Nakamura M, Iwagami M, Hirosawa K, Fujimoto K, Murakami A: Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery: a protocol for a single-centre, randomised controlled trial. BMJ Open. 12(1):e052488, 2022, IF:2.692 /CI:0.
48. Rhee J, Chan TC, Chow SS, Di Zazzo A, Inomata T, Shih KC, Tong L: A Systematic Review on the Association Between Tear Film Metrics and Higher Order Aberrations in Dry Eye Disease and Treatment. Ophthalmol Ther. 11(1):35-67, 2022, IF:3.536 /CI:1.
49. Sato S, Kainuma K, Noda T, Ebisawa M, Futamura M, Imamura T, Miyagawa A, Nakajima S, Ogawa Y, Inomata T, Kan OK, Kurashima Y, Masaki K, Myojin T, Nishioka Y, Sakashita M, Tamari M, Morita H, Adachi T: Evaluation of adrenaline auto-injector prescription profiles: A population-based, retrospective cohort study within the National Insurance Claims Database of Japan. Allergol Int. 2022, IF:5.836 / CI:0.
50. Zhu J, Inomata T (Corresponding Author), Nakamura M, Fujimoto K, Akasaki Y, Fujio K, Yanagawa A, Uchida K, Sung J, Negishi N, Nagino K, Okumura Y, Miura M, Shokirova H, Kuwahara M, Hirosawa K, Midorikawa-Inomata A, Eguchi A, Huang T, Yagita H, Habu S, Okumura K, Murakami A: Anti-CD80/86 antibodies inhibit inflammatory reaction and improve graft survival in a high-risk murine corneal transplantation rejection model. Sci Rep. 12(1):4853, 2022, IF:4.380 / CI:0.
51. Okumura Y, Inomata T (Corresponding Author), Midorikawa-Inomata A, Sung J, Fujio K, Akasaki Y, Nakamura M, Iwagami M, Fujimoto K, Eguchi A, Miura M, Nagino K, Hirosawa K, Huang T, Kuwahara M, Dana R, Murakami A: DryEyeRhythm: A reliable and valid smartphone application for dry eye diagnosis. Ocul Surf. 2022, in press, IF:5.033 /CI:0.
52. Miura M, Inomata T (Corresponding Author), Nakamura M, Sung J, Nagino K, Midorikawa-Inomata A, Zhu J, Fujimoto K, Okumura Y, Fujio K, Hirosawa K, Akasaki Y, Kuwahara M, Eguchi A, Shokirova H, Murakami A: Prevalence and characteristics of dry eye disease after cataract surgery: A systematic review and meta-analysis. Ophthalmol Ther. 2022, in press, IF:3.536 /CI:0.

「和文原著【総数１１編・筆頭著者数４編・責任著者(corresponding author)数５編】」
1. 猪俣武範、済陽里佳、藤巻拓郎、小野浩一、中谷智、福村由紀、梅田裕祥、海老原伸行、村上晶: 虹彩全幅切除を併用した先天虹彩嚢胞の一例. 眼臨紀. 3:390-3, 2010.
2. 小野浩一、平塚義宗、田野貴俊、猪俣武範: 南会津・只見町コホート研究：網膜血管径とメタボリックシンドロームの疫学. 順天堂医学. 56:360, 2010.
3. 井上亮, 猪俣武範, 田村薫, 林誠一郎, 横山利幸, 晶村: ベバシズマブ硝子体注入を併用した23ゲージ硝子体手術の検討. 臨床眼科. 64:863-7, 2010
4. 猪俣武範、武田淳史、本田理峰、松井麻紀、土至田宏、太田俊彦、小池道明、矢田清身、村上晶: ガンシクロビルの点滴と点眼が奏効したサイトメガロウイルス角膜内皮炎の1例. 臨床眼科. 65:875-9, 2011.
5. 宮本静華, 猪俣武範 (責任著者), 中谷智, 平塚義宗, 村上晶: アイバンク提供眼の眼球保存液におけるMRSA汚染の検討. 臨床眼科. 71(10):1549-55, 2017.
6. 水野樹, 稲田英一, 猪俣武範, 嶋田晶江, 川崎志保理, 天野篤, 吉川努, 国松修一: 手術の術前時間と術後時間の長さ : 外科系診療科と麻酔法による差. 臨床麻酔. 41(10):1411-5, 2017.
7. 水野樹, 稲田英一, 猪俣武範, 吉川努, 国松修一.: 全身麻酔下に施行された脳神経外科手術における術前時間、手術時間、術後時間. 麻酔. 67(12):1264-8, 2018.
8. 猪俣武範 (責任著者): ResearchKitを用いて作成したiPhoneアプリケーション「ドライアイリズム」によるドライアイの啓発と新しい大規模臨床研究. あたらしい眼科. 35(7), 2018.
9. 水野樹, 猪俣武範 (責任著者): ラテックス製手術用手袋の熱老化特性. 手術医学. 40(3):153-7, 2019.
10. 藤尾健太, 猪俣武範 (責任著者), 中村正裕, 岩上将夫, 海老原伸行, 中村真浩, 藤澤空見子, 武藤香織, 岡野光博, 奥村雄一, 井手拓磨, 野尻宗子, 赤崎安序, 長尾雅史, 藤本啓一, 村上晶: 患者・市民参画を取り入れた花粉症用スマートフォンアプリケーション”アレルサーチ”による双方向性研究実現に向けた研究. 臨眼. 75(10):1328-37, 2021.
11. 猪俣武範 (責任著者): 花粉症の多様な症状の層別化〜患者・市民参画を取り入れたスマホアプリを用いたクラウド型大規模横断観察研究. Allos ergon. 1(3):347-55, 2021.

「英文総説【総数10編・筆頭著者数4編・責任著者(corresponding author)数5編】」
1. Inomata T (Corresponding Author): A New Immunotherapy Using Regulatory T-Cells for High-Risk Corneal Transplantation. Juntendo Medical Journal. 63(1):2-7, 2017, IF: – / CI:5.
2. Tahvildari M, Inomata T (Co-1st Author), Amouzegar A, Dana R: Regulatory T cell modulation of cytokine and cellular networks in corneal graft rejection. Curr Ophthalmol Rep. 6(4):266-74, 2018, IF: – / CI:11.
3. Heidari M, Noorizadeh F, Wu K, Inomata T (Co-Last Author), Mashaghi A: Dry Eye Disease: Emerging Approaches to Disease Analysis and Therapy. J Clin Med. 8(9), 2019, IF: 4.242 / CI:32.
4. Di Zazzo A, Lee S-M, Sung J, Niutta M, Coassin M, Mashaghi A, Inomata T (Last Author): Variable Responses to Corneal Grafts: Insights from Immunology and Systems Biology. J Clin Med. 9(2), 2020, IF:4.242 / CI:11.
5. Inomata T (Corresponding Author), Sung J, Nakamura M, Fujisawa K, Muto K, Ebihara N, Iwagami M, Nakamura M, Fujio K, Okumura Y, Okano M, Murakami A: New medical big data for P4 medicine on allergic conjunctivitis. Allergol Int. 69(4):510-8, 2020, IF:5.836 / CI:15.
6. Okumura Y, Inomata T (Corresponding Author), Iwata N, Sung J, Fujimoto K, Fujio K, Midorikawa-Inomata A, Miura M, Akasaki Y, Murakami A: A Review of Dry Eye Questionnaires: Measuring Patient-Reported Outcomes and Health-Related Quality of Life. Diagnostics (Basel). 10(8), 2020, IF:3.706 / CI:26.
7. Grasso A, Di Zazzo A, Giannaccare G, Sung J, Inomata T, Shih KC, Micera A, Gaudenzi D, Spelta S, Romeo MA, Orsaria P, Coassin M, Altomare V: Sex Hormones Related Ocular Dryness in Breast Cancer Women. J Clin Med. 10(12), 2021, IF:4.242 / CI:3.
8. Inomata T (Corresponding Author), Sung J, Nakamura M, Iwagami M, Okumura Y, Fujio K, Akasaki Y, Fujimoto K, Yanagawa AI, Midorikawa-Inomata A, Nagino K, Eguchi A, Shokirova H, Zhu J, Miura M, Kuwahara M, Hirosawa K, Huang T, Morooka Y, Murakami A: Cross-hierarchical Integrative Research Network for Heterogenetic Eye Disease Toward P4 Medicine: A Narrative Review. Juntendo Medical Journal. advpub, 2021, IF: – / CI:0.
9. Kitazawa K, Deinhardt-Emmer S, Inomata T, Deshpande S, Sotozono C: The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies. Cells. 10(4), 2021, IF: 6.600 / CI:6.
10. Zhu J, Inomata T (Corresponding Author), Shih KC, Okumura Y, Fujio K, Huang T, Nagino K, Akasaki Y, Fujimoto K, Yanagawa A, Miura M, Midorikawa-Inomata A, Hirosawa K, Kuwahara M, Shokirova H, Eguchi A, Morooka Y, Chen F, Murakami A: Application of Animal Models in Interpreting Dry Eye Disease. Front Med (Lausanne). 9:830592, 2022, IF: 5.093 / CI:0.

「和文総説【総数２０編・筆頭著者数1８編・責任著者(corresponding author)数1８編】」
1. 猪俣武範 (責任著者): 世界のドライアイの考え方の比較. あたらしい眼科. 34(3):371-80, 2017.
2. 猪俣武範 (責任著者): コンタクトレンズ関連ドライアイ. 日本コンタクトレンズ学会誌. 59(3):177, 2017.
3. 猪俣武範、本田美樹: 硝子体注射の日米ガイドラインの比較. 眼科手術. 30:5-11, 2017.
4. 猪俣武範 (責任著者): 制御性T細胞(Treg)について. あたらしい眼科. 35(9):1255, 2018.
5. 猪俣武範 (責任著者): IoMTは医療をどう変えるか〜医療におけるデジタルユビキティへの変革〜. Journal of Internet of Medical Things. 1(1):4-9, 2018.
6. 奥村雄一, 猪俣武範 (責任著者): HEMA (2-hydroxyethyl methacrylate). 日本コンタクトレンズ学会誌. 61(1), 2019.
7. 猪俣武範 (責任著者): ResearchKitを用いたアプリケーションによる新しい医療ビッグデータの可能性. Journal of Internet of Medical Things. 2(1):10-5, 2019.
8. 猪俣武範 (責任著者): 新しい医療ビッグデータとドライアイ. Frontiers in Dry Eye. 14(1):16-9, 2019.
9. 猪俣武範 (責任著者): 新しい医療ビッグデータによる医療のパラダイムシフト. 保健の科学. 62(1):4-9, 2020.
10. 猪俣武範 (責任著者): モバイルヘルスによるP4 Medicineの実現. 眼科グラフィック. 9:532-7, 2020.
11. 猪俣武範 (責任著者): 令和元年度日本眼科学会学術奨励賞受賞論文総説, モバイルヘルスを利用した医療ビッグデータ解析による個別化医療の実現：iPhoneアプリケーション「ドライアイリズムⓇ」を用いたクラウド型大規模臨床研究. 日眼会誌. 124(11):861-72, 2020.
12. 猪俣武範 (責任著者): スマホアプリで収集した医療ビッグデータ解析によるドライアイのP4 Medicine実現のための研究. 「研究成果を社会へ」人生100年時代を見据えた運動の生活カルチャー化への挑戦. Active. 6:15, 2020.
13. 村上晶, 藤巻拓郎, 舟木俊成, 山口昌大, 川村雄一, 藤木慶子, 岩田文乃, 平形寿彬, 平塚義宗, 土至田宏，小野浩一, 中谷智, 太田俊彦, 猪俣武範, 松田彰, 海老原伸行, 横山利幸, 早川むつ子: 眼科遺伝学― 分子遺伝学と難治性眼疾患治療への展開―. 日眼会誌. 125(3):210-29, 2021
14. 猪俣武範 (責任著者): モバイルヘルスから収集した医療ビッグデータを用いたデータ駆動型解析によるドライアイに対するP4 Medicineの実現. 日本の眼科. 92(1), 2021.
15. 猪俣武範 (責任著者): 患者の主観的な指標に基づく多様なドライアイ症状の定量化による予測・予防・個別化医療の実現. 日本の眼科. 92(2):141-2, 2021.
16. 猪俣武範 (責任著者): スマホアプリを用いたドライアイ未診断者の特徴の解明. Frontiers in Dry Eye. 16(1):30-1, 2021.
17. 猪俣武範 (責任著者): ドライアイ用スマホアプリによる新しい医療ビッグデータの収集 P4 Medicineの実現に向けて. medicina. 58(6):850-4, 2021.
18. 猪俣武範 (責任著者): モバイルヘルスアプリを利用した花粉症に対するP4 Medicineに基づくヒト中心のユビキタス医療の実現. アレルギーの臨床. 41(8):717-22, 2021.
19. 猪俣武範 (責任著者): Society5.0時代の医療. Journal of Internet of Medical Things. 4(1):4-7, 2021.
20. 猪俣武範 (責任著者): 第43回(令和2年度)順天堂大学医学部同窓会学術奨励賞抄録データ駆動型多階層横断的研究による眼疾患に対する「P4 Medicine」の実現. 茶崖. 182:47, 2021.

「英文著書」
該当なし

「和文著書」
1. 猪俣武範. ハーバード×MBA×医師目標を次々に達成する人の最強の勉強法: ディスカヴァー・トゥエンティワン; 2016.
2. 猪俣武範. ハーバード×MBA×医師働く人のための最強の休息法: ディスカヴァー・トゥエンティワン; 2017.
3. 猪俣武範、中尾武史. ハーバード大学眼科イラストレイテッドマニュアル: 金原出版; 2017.
4. IoMT学会編集委員会. IoMTの可能性と未来. In: 猪俣武範, editor. Journal of Internet of Medical Things. 1. 東京: メディカルレビュー; 2018.
5. IoMT学会編集委員会. IoMTのUP-TO-DATE. In: 猪俣武範, editor. Journal of Internet of Medical Things. 2. 東京: メディカルレビュー; 2019.
6. 猪俣武範, 松尾剛行. 医者と弁護士が知っている日本の病院 7つのなぜ: クロスメディア・パブリッシング(インプレス); 2019.
7. スマホと眼 Pros & Cons. 猪俣武範, editor: 全日本病院出版会; 2020.
8. IoMT学会編集委員会. IoMTのエコシステム./New insights of IoMT. In: 猪俣武範, editor. Journal of Internet of Medical Things. 3. 東京: メディカルレビュー; 2020.
9. IoMT学会編集委員会. インフラ化するIoMT. 猪俣武範, editor: メディカルレビュー; 2021.
10. 一般社団法人日本医療戦略研究センター(J-SMARC). 戦略的医療マネジメント―VUCA時代を乗り切るMBA視点: 中外医学社; 2021.

研究者

教育活動

ホームページURL

【学校法人順天堂】研究者情報データベース

研究業績詳細

猪俣 武範（イノマタ タケノリ）

猪俣武範（イノマタタケノリ）